Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eye (Lond) ; 38(9): 1681-1686, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38409307

RESUMO

OBJECTIVE: To define how estimates of keratoconus progression following collagen cross-linking (CXL) vary according to the parameter selected to measure corneal shape. MATERIALS AND METHODS: We estimated progression following CXL in 1677 eyes. We compared standard definitions of keratoconus progression based on published thresholds for Kmax, front K2, or back K2, or progression of any two of these three parameters, with the option of an increased threshold for Kmax values ≥ 55D. As corneal thickness reduces unpredictably after CXL, it was excluded from the principal analysis. We then repeated the analysis using novel adaptive estimates of progression for Kmax, front K2, or back K2, developed separately using 6463 paired readings from keratoconus eyes, with a variation of the Bland-Altman method to determine the 95% regression-based limits of agreement (LoA). We created Kaplan-Meier survival plots for both standard and adaptive thresholds. The primary outcome was progression five years after a baseline visit 9-15 months following CXL. RESULTS: Progression rates were 8% with a standard (≥ 1.5D) threshold for K2 or 6% with the static multi-parameter definition. With a ≥ 1D threshold for Kmax, the progression was significantly higher at 29%. With adaptive Kmax or K2, the progression rates were similar (20%) but less than with the adaptive multi-parameter method (22%). CONCLUSIONS: Estimates of keratoconus progression following CXL vary widely according to the reference criteria. Using adaptive thresholds (LoA) to define the repeatability of keratometry gives estimates for progression that are markedly higher than with the standard multi-parameter method.


Assuntos
Colágeno , Córnea , Topografia da Córnea , Reagentes de Ligações Cruzadas , Progressão da Doença , Ceratocone , Fármacos Fotossensibilizantes , Riboflavina , Ceratocone/tratamento farmacológico , Ceratocone/diagnóstico , Ceratocone/fisiopatologia , Humanos , Colágeno/metabolismo , Reagentes de Ligações Cruzadas/uso terapêutico , Masculino , Feminino , Adulto , Fármacos Fotossensibilizantes/uso terapêutico , Riboflavina/uso terapêutico , Córnea/patologia , Raios Ultravioleta , Acuidade Visual/fisiologia , Adulto Jovem , Fotoquimioterapia/métodos , Paquimetria Corneana , Adolescente , Substância Própria/metabolismo , Substância Própria/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA